Section 7 of DCA : Section 7: The Drugs Consultative Committee
DCA
JavaScript did not load properly
Some content might be missing or broken. Please try disabling content blockers or use a different browser like Chrome, Safari or Firefox.
Explanation using Example
Imagine a pharmaceutical company in India has developed a new drug and is seeking approval for its nationwide distribution. The Central Government, aiming to ensure that the drug meets safety standards across all states, decides to consult with the Drugs Consultative Committee (DCC) as per Section 7 of The Drugs and Cosmetics Act, 1940.
In this scenario, the DCC, comprising representatives from the Central and State Governments, convenes to review the drug's compliance with safety regulations. Their role is to provide advice that helps maintain uniform drug administration standards across India. After thorough deliberation, the DCC offers recommendations to the Central and State Governments, which could include additional testing requirements or specific labeling guidelines to ensure consumer safety.